key: cord-0988749-n50l0xan
authors: Fahmi, Amal; Brügger, Melanie; Démoulins, Thomas; Zumkehr, Beatrice; Oliveira Esteves, Blandina I.; Bracher, Lisamaria; Wotzkow, Carlos; Blank, Fabian; Thiel, Volker; Baud, David; Alves, Marco P.
title: SARS-CoV-2 can infect and propagate in human placenta explants
date: 2021-11-04
journal: Cell Rep Med
DOI: 10.1016/j.xcrm.2021.100456
sha: edf5e8a75693f931b24955238a4a6b20f22cec99
doc_id: 988749
cord_uid: n50l0xan

The ongoing SARS-CoV-2 pandemic continues to lead to high morbidity and mortality. During pregnancy, severe maternal and neonatal outcomes and placental pathological changes have been described. We evaluate SARS-CoV-2 infection at the maternal-fetal interface using precision-cut slices (PCSs) of human placenta. Remarkably, exposure of placenta PCSs to SARS-CoV-2 leads to a full replication cycle with infectious virus release. Moreover, the susceptibility of placental tissue to SARS-CoV-2 replication relates to the expression levels of ACE2. Viral proteins and/or RNA are detected in syncytiotrophoblast, cytotrophoblasts, villous stroma, and possibly Hofbauer cells. While SARS-CoV-2 infection of placenta PCSs does not cause a detectable cytotoxicity nor a pro-inflammatory cytokine response, an upregulation of one order of magnitude of interferon type III transcripts is measured. In conclusion, our data demonstrate the capacity of SARS-CoV-2 to infect and propagate in human placenta and constitute a basis for further investigation of SARS-CoV-2 biology at the maternal-fetal interface.

The ongoing coronavirus disease 2019 pandemic is caused by infection with 20 severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), a betacoronavirus 21 with major similarities to SARS-CoV, causative pathogen of SARS. The cell surface receptor 22 for both viruses, the angiotensin-converting enzyme 2 (ACE2), is highly expressed by 23 epithelial cells of the upper and lower respiratory tract 1 . In addition, SARS-CoV and SARS-24

CoV-2 both use the endogenous plasma membrane serine protease TMPRSS2 as factor for 25 priming and activation. Interestingly, the expression of ACE2 and TMPRSS2 are not 26 restricted to the lung tissue and also expressed in cardiomyocytes, enterocytes, endothelial 27 cells and placental trophoblasts, indicating that SARS-CoV-2 may have a wide cellular 28 tropism 2-6 . Several extrapulmonary complications are described, including acute cardiac and 29 kidney injury, neurological and gastrointestinal manifestations, endothelial damage and 30 thrombosis in various organs 7,8 . 31 There is epidemiologic evidence that pregnant women have an elevated risk of developing 32 severe COVID-19 in comparison to age-matched non-pregnant woman 9-12 . Also, up to 40 % 33 of SARS-CoV-2 infections during pregnancy are associated with adverse outcomes such as 34 prematurity, miscarriage, pre-eclampsia and stillbirth 5,13-15 . Indeed, large cohort studies have 35

shown that preterm birth, stillbirth and pre-eclampsia were all significantly increased 16 . 36 interface, we used an ex vivo model based on organotypic cultures of precision-cut slices 48 (PCSs) of human placenta and evaluated the permissiveness and tropism of third-trimester 49 placenta to SARS-CoV-2. 50 calculating co-localization percentages, we found a tight relation between CANX and SARS-100

CoV-2 N protein signals (co-localization index of 95.8 and 96.4 %, at 72 and 120h p.i., 101 respectively; Figure 2C , lower panel). To validate the co-localization, we conducted 102 additional experiments using the ER chaperone ERp57 (also known as glucose-regulated 103 protein, 58-kD, GRP58) 34 . Similar to CANX, we observed co-localization of N protein and 104

ERp57 at the level of syncytiotrophoblast and occasionally in the villi stroma ( Figures 3D) . 105 We performed a complementary approach with S protein and detected an increase of the 106 signal over time p.i., indicating replication of SARS-CoV-2. Remarkably, we didn't detect co-107 localization of S protein and ERp57 in any of the donors tested, pointing to distinct 108 maturation mechanisms used by N and S proteins in the placenta secretory pathway ( Figure  109 2E). 110

Finally, we aimed to evaluate the virus-induced cytotoxicity, inflammatory, and interferon 111 (IFN) type I and III responses following infection of placenta PCSs. SARS-CoV-2 compared 112 to mock controls, did not lead to significant increase in lactate dehydrogenase (LDH), a 113 common marker of tissue injury 35 , nor pro-inflammatory cytokines correlating with COVID-19 114 severity ( Figure 3A , B) 36 . Increased levels of IFN-s were measured, while not reaching 115 conflicting. Some indicate a consistent expression throughout gestational stages in human, 127 and others mention more variable levels in particular for the TMPRSS2 protease 6,37-41 . In 128 agreement with this, in uninfected tissue, we observed a high donor variability in the 129 expression of both molecules, spanning throughout 3 orders of magnitude. Remarkably, we 130 found a significant association between ACE2 levels and placenta permissiveness to SARS-131

CoV-2 infection. Concerning the cellular targets of the virus, our data point to the broad cell 132 tropism of SARS-CoV-2. We detected viral RNA and/or viral proteins in several cellular 133 compartments such as syncytiotrophoblast, trophoblasts, mesenchymal/stromal cells, and 134 possibly Hofbauer macrophages, as previously observed in case reports 19,42-45 . 135 We detected co-localization of ER-associated molecules, CANX and ERp57, with SARS-136

CoV-2 N protein. Given that CANX was shown, in the HEK293T cell line, to chaperone 137 coronavirus replication through the maturation of surface glycoproteins, the high co-138 localization index of CANX and N protein suggests that SARS-CoV-2 may use similar 139 mechanism in human placenta 46 . Contrary to N protein, we didn't detect the S protein in 140

conjunction with the ER marker tested, indicating possibly distinct localization of N and S 141 proteins within the secretory pathway of placenta cells. In agreement with this, the structural 142 proteins S, M, and E are found in different subcellular compartments during replication of 143 SARS-CoV 47 . Our observations are compatible with coronavirus life cycle, characterized by 144 a profound rearrangement of ER membranes into a complex replication network of double-145 vesicle membranes 48, 49 . In line with this, a recent study suggests an alteration of the 146 endocytic pathway at the maternal-fetal interface during COVID-19 50 . 147 antiviral defense 54 . In addition, our data are compatible with a paper from Mourad et al. 154 suggesting that the placental IFN responses to SARS-CoV-2 are related to disease severity 155 55 . 156

In summary, we used an advanced ex vivo model to study the interaction of SARS-CoV-2 at 157 the human maternal-fetal interface. This system could be used as a translational platform for 158 the screening of antivirals against SARS-CoV-2 and other pathogens potentially targeting the 159 placenta. We demonstrated with independent methods the susceptibility of the human 160 placenta towards SARS-CoV-2 infection with the release of replication-competent virions. 161

These results stress the requirement to perform further work to better evaluate the risks and 162 define the appropriated measures to protect women from adverse pregnancy outcomes 163 related to 165

Considering the lack of a model of COVID-19 during gestation, our experimental approach 167 allows the study of the biology of SARS-CoV-2 in human placenta. However, some 168 limitations should be mentioned. While placenta PCSs are helpful to understand the initial 169 phases of SARS-CoV-2 infection, it doesn't constitute an appropriate system for the 170 assessment of the placental barrier and long-term outcomes influenced by immune 171 components. Also, since we used third trimester placenta, we cannot make conclusions 172 regarding the replication of SARS-CoV-2 during early pregnancy. However, SARS-CoV-2 173 RNA has been detected in the placenta during the initial trimesters of pregnancy, indicating 174 that SARS-CoV-2 may also propagate in this tissue during that period 56,57 . It remains unclear 175 how the virus may reach the placental tissue. The RNA of SARS-CoV-2 is commonly 176 detected in serum or plasma of COVID-19 patients but there is no information regarding the 177 presence of infectious virus in peripheral blood 7 . In a recent study, it was hypothesized that 178 placental tissue 58 Gibco) prior to exposure to air, and completed PneumaCult ALI medium, supplemented with 301 4 µg/ml heparin (Stem Cell Technologies), 5 µM hydrocortisone, and 100 µg/ml primocin was 302 added to the basolateral medium to induce differentiation of the cells. The basal medium was 303 changed every 2-3 days and cultures were maintained at 37°C, 5% CO 2 until the appearance 304 of ciliated cells and mucus production. To get rid of excessive mucus production, the cell 305 layer was washed once a week with pre-warmed 250 l of HBSS during 20 min at 37°C. 306

Switzerland and was authorized by the Federal authorities (authorization no. A202819). Entry 322 into the BSL3 laboratory is only possible following an advanced training and with appropriate 323 personal protective equipment, including a Tyvek overall and hood (both 3M), and a Jupiter 324 air respirator equipped with an HEPA filter system (3M). 325 326

The infection of placenta PCSs with SARS-CoV-2 was performed by applying the inoculum 329 at a rate of 5x10 5 PFU per PCS during 4-6 h at 37°C and 5% CO 2 , followed by two times 330 wash with pre-warmed PBS. As control, the culture supernatant of mock-infected Vero E6 331 cells was used. Over the course of infection, supernatants and tissue samples were 332 harvested at selected time points and stored at -70°C until further analysis. Placenta PCSs 333 were fixed in 4% formalin (Formafix) for 24 h for subsequent analysis. For infection of WD-334 NECs, the virus inoculum was applied apically at a rate of 5x10 4 PFU per insert (representing 335 a MOI of about 0.1 PFU per cell) during 2-3 h at 37°C and 5% CO 2 , followed by three times 336 wash with pre-warmed PBS. Pathology, University of Bern, Switzerland. In brief, human placenta PCSs were transferred 378 into embedding cassettes and properly labeled. The embedding cassettes were dehydrated 379 using a series of increasing concentration of Ethanol (70%, 96% to 100%). As a final step of 380 dehydration, embedding cassettes were transferred to Xylol. Next, embedding cassettes 381 were transferred to the beaker containing melted paraffin for 45 min. Paraffin blocks were 382 obtained using a tissue embedding machine. Then, 5 μm thick sections were cut using a 383 Leica RM2135 microtome (Leica Biosystems). Next, the formalin-fixed paraffin-embedded 384 (FFPE) sections were mounted on glass slides (Fisherbrand Superfrost Plus; Fisher 385 Scientific). FFPE sections were dewaxed at 60°C for 1 hour followed by standard procedure 386 for rehydration with Xylol and a series of decreasing concentration of Ethanol (100%, 95%, 387 80% to 70%). In situ hybridization of SARS-CoV-2 RNA was done using the RNAscope 388 technology according to manufacturers' instructions (ACD Bio-Techne). The dewaxed 389 sections were treated with RNAscope hydrogene peroxide for 10 min at room temperature. 390

After washing steps in distilled water, the slides were heated with RNAscope Target Retrieval 391 Reagent at 99°C for 15 min. After rinsing with distilled water, slides were put in 100% ethanol 392 for 3 min. After dry out, drops of RNAscope Protease Plus Reagent were added until full 393 coverage of the section. During the whole assay, slides were put on the HybEZTM Slide 394

Rack (ACD Bio-Techne), and incubation steps occurred in the HybEZTM Oven (ACD Bio-395 Techne). Finally, hybridization was performed using SARS-CoV-2 target probes (V-nCoV20 396 19-S, ACD Bio-Techne) at 40°C for 2 h. Then, slides went through amplification cycles, 397 following manufacturer's instructions using RNAscope 2.5 HD Detection Reagent-RED Kit. 398

After each amplification step, slides were washed in RNAscope Wash buffer Reagent. 399

Hybridization signals were detected with Fast RED (Advanced Cell Diagnostics), followed by 400 counterstaining with hematoxylin (Roth). Finally, slides were mounted with VectaMount (Nikon Instruments Europe BV). 404

Immunofluorescence 406 Human placenta PCSs were fixed in 4% formalin (Formafix) overnight and were embedded 407 in paraffin using the standard protocol described in the previous section. Then, 5 μm thick 408 sections were cut with a Leica RM2135 microtome ( The Prism 9 software (GraphPad) was used for statistical analysis. To determine differences 444 between two groups, two-sided t-test was used. Associations were tested using the 445 Spearman rank correlation test. A p<0.05 was considered statistically significant. Del Valle, D.M., Kim-Schulze, S., Huang, H.H., Beckmann, N.D., Nirenberg, S., 575 Wang, B., Lavin, Y., Swartz, T.H., Madduri, D., Stock, A., et al. (2020) . An inflammatory 576 cytokine signature predicts COVID-19 severity and survival. Nature medicine 26, 1636-1643. 577 10.1038/s41591-020-1051-9. 578 37.

Bloise, E., Zhang, J., Nakpu, J., Hamada, H., Dunk, C.E., Li, S., Imperio, G.E., 579 Nadeem, L., Kibschull, M., Lye, P., et al. (2020) . Expression of severe acute respiratory 580 syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and 581 transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal 582 interface in pregnancies complicated by preterm birth or preeclampsia. Am J Obstet Gynecol. 

The SARS-CoV-2 receptor

ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome 463 study

SARS-CoV-2 ACE-receptor detection in the placenta throughout pregnancy

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Thrombosis, and Angiogenesis in Covid-19

Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status -477

Clinical manifestations and outcome 496 of SARS-CoV-2 infection during pregnancy

Second-Trimester Miscarriage in a Pregnant Woman With SARS-CoV-2 Infection

Clinical Characteristics and Outcomes of Hospitalized 502

Women Giving Birth With and Without COVID-19

Outcome of coronavirus 506 spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and 507 meta-analysis

Chronic Histiocytic

Intervillositis with Trophoblast Necrosis are Risk Factors Associated with Placental Infection 511 from Coronavirus Disease 2019 (COVID-19) and Intrauterine Maternal-Fetal Severe Acute 512 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal 591 dyads

Coronavirus Disease 2019 during Pregnancy: Clinical 594 and in Vitro Evidence against Placenta Infection at Term by Severe Acute Respiratory 595

Syndrome Coronavirus 2

Expression of severe acute respiratory 598 syndrome coronavirus 2 cell entry genes

transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal 600 interface in pregnancies complicated by preterm birth or preeclampsia

Molecular Pathology Analysis of SARS-CoV-2 in

Placenta from a Pregnant Woman and Fetus with

Hofbauer cells and 608 coronavirus disease 2019 (COVID-19) in pregnancy: Molecular pathology analysis of villous 609 severe acute respiratory syndrome coronavirus surface proteins S, M and E. The Journal of 627 general virology

SARS-coronavirus replication is 630 supported by a reticulovesicular network of modified endoplasmic reticulum

The intracellular sites of early replication and budding of 634

Differential Expression of Rab5 and Rab7 Small 637

GTPase Proteins in Placental Tissues From Pregnancies Affected by Maternal Coronavirus 638 Disease

Maternal respiratory

SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the 642 maternal-fetal interface

Persistence of SARS-CoV-2 in the 661 first trimester placenta leading to transplacental transmission and fetal demise from an 662 asymptomatic mother

ACE2 Is Expressed in Immune Cells That Infiltrate 665 the Placenta in Infection-Associated Preterm Birth

Precision-cut slice culture method for rat placenta

Characterization of pediatric cystic fibrosis 671 airway epithelial cell cultures at the air-liquid interface obtained by non-invasive nasal 672 cytology brush sampling

Analysis of relative gene expression data 674 using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method

signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate 691 interferons

Role of deficient type 694 III interferon-lambda production in asthma exacerbations